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Introduction: A previous genome-wide association study found three genetic loci,
rs9388451, rs10428132, and rs11708996, to increase the risk of Brugada Syndrome
(BrS). Since the effect of these loci in the general population is unknown, we aimed
to investigate the effect on electrocardiogram (ECG) parameters and outcomes in the
general population.
Materials and Methods: A cohort of 6,161 individuals (median age 45 [interquartile
range (IQR) 40–50] years, 49% males), with available digital ECGs, was genotyped
and subsequently followed for a median period of 13 [IQR 12.6–13.4] years. Data on
outcomes were collected from Danish administrative healthcare registries. Furthermore,
∼400,000 persons from UK Biobank were investigated for associations between the
three loci and cardiac arrest/ventricular fibrillation (VF).
Results: Homozygote carriers of the C allele in rs6800541 intronic to SCN10A had
a significantly larger J-point elevation (JPE) compared with wildtype carriers (11 vs.
6 µV, P < 0.001). There was an additive effect of carrying multiple BrS-associated
risk alleles with an increased JPE in lead V1. None of the BrS-associated genetic
loci predisposed to syncope, atrial fibrillation, or total mortality in the general Danish
population. The rs9388451 genetic locus adjacent to the HEY2 gene was associated
with cardiac arrest/VF in an analysis using the UK Biobank study (odds ratio = 1.13
(95% confidence interval: 1.08–1.18), P = 0.006).
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Conclusions: BrS-associated risk alleles increase the JPE in lead V1 in an additive
manner, but was not associated with increased mortality or syncope in the general
population of Denmark. However, the HEY2 risk allele increased the risk of cardiac
arrest/VF in the larger population study of UK Biobank indicating an important role of
this common genetic locus.
Keywords: Brugada Syndrome, single nucleotide polymorphism, electrocardiogram, general population, mortality
INTRODUCTION
Recent advances in the field of genetics have led to an increased
focus on the genetic component of cardiac diseases associated
with sudden cardiac death (SCD) (Ghouse et al., 2015; Manrai
et al., 2016). Genetic testing has become an important tool in
the clinical setting, contributing to the identification of patients
and family members at risk of having an inherited cardiac
disease. Brugada Syndrome (BrS) is an inherited arrhythmic
disease characterized by ST-segment elevations in leads V1-V2
and an increased risk of ventricular arrhythmias and sudden
cardiac death (Nielsen et al., 2013). Currently more than 20 genes
have been associated with BrS, although very few monogenic
forms of BrS have been identified (Watanabe and Minamino,
2016).
A recent genome-wide association study (GWAS) identified
three loci (rs9388451 in proximity to HEY2; T>C, rs10428132
close to SCN10A; T>G, and rs11708996 close to SCN5A;
G>C) to be associated with BrS. Patients carrying more
than four of these risk alleles had an odds ratio (OR) of
21.5 for BrS, compared with patients carrying zero or one
risk allele. All three GWAS-identified loci are presumed to
affect the sodium current and, in addition, the HEY2 loci
has been associated with diminished transmural differences
in the Ito current in cardiac myocytes (Bezzina et al.,
2013; Veerman et al., 2017). Since these three variants are
common also in the background population, our aim was to
investigate the effect of these single nucleotide polymorphisms
(SNPs) on the electrocardiogram (ECG), syncope, BrS,
and/or atrial fibrillation (AF), and mortality in the general
population.
MATERIAL AND METHODS
Study Population Inter99
The study population was drawn from the Inter99 study.
The Inter99 study was a population-based randomized lifestyle
intervention trial (CT00289237, ClinicalTrials.gov) investigating
the effects of lifestyle intervention on the risk of cardiovascular
death. Genotyping was performed on 6,161 individuals from the
Inter99 study cohort (Glümer et al., 2003). All participants have
given their informed consent and were, by self-report, of Danish
origin. The study population included individuals above the age
of 29 years. The study design has previously been described in
detail (Jørgensen et al., 2003). The protocol was in accordance
with the Helsinki declaration and approved by the local ethical
committee.
Study Population UK Biobank
The three genetic loci were further investigated in individuals
from the open resource UK Biobank study including 408,961
white British participants with European ancestry, recruited
between 2006 and 2010. The UK Biobank project is a large
prospective cohort study of approximately 500,000 individuals
from the United Kingdom, aged between 40 and 69 at
recruitment. Additional to blood, saliva, and urine samples,
the study contains self-reported information including diet and
exercise habits, physical and cognitive measurements, and data
from medical records and registries (Sudlow et al., 2015).
Genotyping Inter99
The rs11708996 SNP was genotyped on the Illumina Human
Exome Chip 12 v1.0. using the Genotyping module (version
1.9.4) of GenomeStudio software (version 2011.1, Illumina) and
custom cluster data generated from 17,621 Danish DNA samples
analyzed on the same IlluminaHiScan. Since the rs10428132 SNP
was not available on the Exome Chip, another SNP in complete
linkage (rs6800541, 1.0 r2) was chosen, and the abovementioned
genotyping was performed. Individuals were excluded during
quality control (QC) by removing closely related individuals,
individuals with an extreme inbreeding coefficient, individuals
with a low call-rate <90%, individuals with a mislabeled sex
and individuals with a high discordance rate to previously
performed genotypings. Both SNPs were of high quality and in
Hardy-Weinberg equilibrium (HWE) P > 0.05 and call-rates
above 99.9%. European ancestry was confirmed using principal
component analysis (PCA, Supplementary Figure 1). The
rs9388451 SNP was not available on the Human Exome Chip and
the same individuals who passed the abovementioned QC was
therefore genotyped using KASP TM bi-allelic discrimination
(LGC Genomics, Herts, UK), resulting in high quality genotypes
(call-rate 99.3%, HWE P = 0.13).
Genotyping UK Biobank
Genotyping was performed using Applied Biosystems UK
BiLEVE Axiom Array by Affymetrix in the first 50,000
participants, as described previously (Wain et al., 2015), and
using the closely related Affymetrix UK Biobank Axiom Array in
the remaining participants (Welsh et al., 2017). Both arrays were
custom-made and share 95% of marker content1. Several tests
for marker-based and sample-based QC were performed in order
1Genome-wide genetic data on ∼500,000 UK Biobank participants | bioRxiv [cited
2018 Jan 5];Available online at: https://www.biorxiv.org/content/early/2017/07/20/
166298.
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to account for effects such as population structure and batch-
based genotype calling, including tests for PCA, batch effects,
plate effects, departures from HWE, sex effects, array effects,
discordance across control replicates, extreme heterozygosity
and high missing rates, and relatedness. Further details on QC
have been described previously1. Imputation was performed by
Wellcome Trust Centre for Human Genetics using reference
panels from 1000Genomes phase 3 and the Haplotype Reference
Consortium (HRC), as described previously1.
ECG Data Analyses Inter99
All Inter99 participants underwent ECG recording upon
inclusion and ECGs were recorded with the patient at rest and in
a supine position. The V1 and V2 recordings were placed at the
4th intercostal space. All ECGs were digitally recorded and stored
in the MUSE Cardiology Information System (GE Healthcare,
Wauwatosa, Wisconsin) and later processed using version 21 of
the Marquette 12SL algorithm.
ECG parameters were assessed digitally, including heart rate,
PR-interval, QRS-duration, QTc-interval, and J-point elevation
(JPE) and depression in lead V1 and V2. The QT-interval was
corrected for heart rate using Bazett’s formula (QTcB) (Sagie
et al., 1992). Extreme outliers outside mean ± 5 standard
deviations (SD) were removed (PR-interval; n = 6, QRS-
duration; n = 17, QTc-interval; n = 2, JPE V1; n = 11, JPE V2;
n= 8).
In addition, two experienced physicians analyzed all ECGs
manually and independently for the diagnostic type 1 Brugada
pattern (Priori et al., 2015).
Syncope, Arrhythmia, and All-Cause
Mortality Inter99
All Danish residents are assigned a personal and unique
civil registration number, which enables linkage to Danish
nationwide registries on an individual level. The Danish National
Patient Registry (NPR) contains information on all in- and
out-of-hospital patient activities in Denmark since 1978. The
civil registration number was used to access register data
in NPR using the International Classification of Diseases,
10th revision (revised in 1994; ICD-10). We identified all
Inter99 patients who prior to or during follow-up had a
hospital, out-patient clinic, or emergency room discharge
diagnosis with one of the following ICD-10 codes: syncope
(DR559), AF (DI48), BrS (DI472M), and cardiac arrest (DI46).
Information regarding all-cause mortality was extracted from
the Danish Cause of Death Registry (Helweg-Larsen, 2011)
containing data on all deaths among Danish citizens living
in Denmark, Greenland, and the Faroe Islands since 1970.
Patients were included from 1999 to 2001 and followed until
December 17, 2012 when data were retrieved from Danish
nationwide health care registries for assessment of the clinical
outcome.
Statistics Inter99
Continuous variables were assessed using ANalysis Of Variance
(ANOVA) adjusted for age and sex. Follow-up time began on the
day of inclusion and ended at death, emigration, or end of follow
up (December 17, 2012), whichever came first.
For each SNP, Cox regression was used to assess the risk of
syncope, AF, and death when carrying one or two risk alleles
compared with carrying zero risk alleles, assuming an additive
model. Since individuals were included from the age of 30, left-
truncation was used. To assess the effect of the three SNPs,
individuals were categorized into having 0, 1–2, 3–4, or 5–6 risk
alleles and compared with having zero alleles with a Dunnett’s
Post Hoc Test.
The survival plots for each variant illustrate the probability
of survival, when harboring a BrS-associated variant
compared with not harboring a BrS-associated variant.
The combined survival plot only includes individuals with
succeeded genotyping of all three variants. Individuals
with genotyping, but without available ECG, are included
in the survival analyses. The two-tailed log-rank test was
used to test the difference in overall mortality between the
groups.
A P-value of less than 0.05 was considered significant. Since
three SNPs were investigated, Bonferroni correction for multiple
testing was applied. Hence a P-value of 0.05/3 = 0.017, was
needed to obtain statistical significance. Statistical analyses were
conducted using R, version 3.3.2.
Analyses UK Biobank
The three SNPs were further investigated using the tools in the
UK Biobank Michigan PheWeb browser (PheWeb, 2018). The
PheWeb browser has been generated using the UK Biobank
Resource under application number 24460 and enables us to
analyse the phenotypic associations between the three SNPs and
cardiac arrest/VF in individuals from UK Biobank. The analyses
were limited to the ethnic majority of UK Biobank consisting
of 382,000 white individuals to avoid population stratification
biases. To avoid large type I error rates in the analysis of
phenotypes with imbalanced case-control ratios, a generalized
mixed model association test, SAIGE, has been developed and
applied to the UK Biobank dataset. The model also takes sample
relatedness into account, and has previously been described in
detail2.
RESULTS
Inter99
Genotyping was done in 6,161 individuals, and was successful of
all three SNPs in 6,068 individuals. Of these, 73 individuals had
no ECG.
Baseline characteristics of the study population are shown in
Table 1. The associations between the BrS-associated genetic loci
and the JPE in V1 and V2, QTcB, PR-interval, and QRS-duration
are presented in Table 2. Risk allele frequencies (RAFs) are 0.15
for rs11708996, 0.38 for rs6800541, and 0.49 for rs9388451,
respectively.
2Efficiently Controlling for Case-Control Imbalance and Sample Relatedness in
Large-Scale Genetic Association Studies | bioRxiv [cited 2018 Jan 5];Available online
at: https://www.biorxiv.org/content/early/2017/11/24/212357.
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TABLE 1 | Baseline characteristics of the study population.
Clinical characteristics
PARTICIPANT INFORMATION
Number of subjects 6,161
Male gender, n (%) 3,020 (49)
Median age, years (IQR) 45 (40–50)
Median BMI (IQR) 26 (23–29)
ECG MARKERS
Heart rate, bpm (mean ± SD) 67.2 ± 11.3
Sinus bradycardia, n (%)† 1,614 (27)
Brugada type 1 pattern, n‡ 1 (0.02)
BMI, body mass index; bpm, beats per minute; IQR, interquartile range; n, total number
of individuals; SD, standard deviation.
†
Sinus bradycardia defined as heart rate <60 bpm.
‡Manually assessed.
Distribution plots of the JPE in V1 and V2, PR-interval, and
QRS-duration are shown in Supplementary Figure 2.
Registry Data on Syncope, AF, BrS, and
All-Cause Mortality
The median follow-up time was 13 years (interquartile range
(IQR) 12.6–13.4 years). The number of registered events of
syncope, AF, BrS, and cardiac arrest in the study population is
shown in Table 3.
There was no significant effect of carrying BrS risk alleles on
the risk of AF [hazard ratio (HR) 0.94 per allele (CI 0.81–1.09)]
or syncope [HR 1.02 per allele (CI 0.88–1.18)].
Survival plots displaying the probability of survival during
follow-up in different age groups are shown in Figure 1. There
was no significant association between each risk variant and the
hazard risk of death from all causes [rs6800541; HR 1.01 (95%
CI 0.86–1.19), P = 0.9, rs9388451; HR 1.04 (95% CI 0.88–1.23),
P = 0.6, rs11708996; HR 0.83 (95% CI 0.65–1.06), P = 0.14].
Furthermore, examining the additive effect of carrying multiple
BrS-associated risk alleles, there was no difference in mortality
when carrying 0, 1–2, 3–4, and 5–6 alleles [HR 0.95 per allele
category, (95% CI 0.78–1.15), P = 0.57].
Effect on J-Point Elevation
Homozygote carriers of the SCN10A rs6800541 variant had an
increase in JPE compared to wildtype in both lead V1 and V2
(5 µV, 95% CI, P < 0.001 and 8 µV, P < 0.001, respectively)
(Table 2). Heterozygote carriers of rs6800541 were not associated
with an increased JPE in lead V2, but had a borderline significant
JPE in lead V1 compared to non-carriers. Harboring any of the
SCN5A andHEY2 variants did not significantly affect the J-point.
When observing the additive effect of carrying multiple BrS-
associated risk alleles, there was a dose-response association, with
an increased JPE in lead V1 with increasing numbers of BrS-
associated risk alleles. Carrying five or six BrS-associated risk
alleles increased the J-point in V1 with 17.1 µV (95% CI: 11.0–
23.2, P< 0.001) (Table 4, Figure 2). The same additive effect was,
however, not observed in lead V2 (see Supplementary Figure 3).
Figure 3 shows that the number of risk alleles affected JPE in both
genders.
Effect on the PR-Interval, QRS Duration,
and QTc Interval
Homozygote carriers of the rs11708996 risk variant located
intronic to SCN5A had a shortened QTc interval (P = 0.003).
Both the rs11708996 and rs6800541 risk variants were associated
with a prolonging effect on the PR interval (P < 0.001 and
P < 0.001, respectively) and a prolonging effect on the QRS
interval (P = 0.001 and P < 0.001, respectively). Carriers of
the rs9388451 risk variant located downstream to HEY2 had a
prolonged PR interval (P = 0.03) and a shortened QRS interval
compared with non-carriers (P = 0.02).
UK Biobank
Using the UK Biobank data, analyzed with theMichigan PheWeb
browser, we show that the rs9388451 genetic locus close to the
HEY2 gene is associated with cardiac arrest/VF ICD-9 code 427.4;
1,137 cases versus 380,919 controls, allele frequency 0.52, beta-
value 0.12 corresponding to OR = 1.13 (95% CI: 1.08–1.18),
P = 0.006). QQ plot and corresponding lambda values of a
GWAS on ICD-9 code 427.4 are shown in Figure 4. A list of
found associations with a P-value above 1.0 × 10−5 are shown
in Supplementary Table 1.
DISCUSSION
In a large cohort representing the general middle-aged
population in Denmark we found that carrying BrS-associated
risk alleles in SCN5A, SCN10A, andHEY2, did not associate with
an increased risk of death from all causes. Neither was there an
increased risk regarding syncope or AF. Interestingly, we found
that carrying an increasing number of BrS-associated risk alleles
increased the JPE in lead V1 in an additive manner. Furthermore,
the HEY2 risk allele was associated with cardiac arrest/VF in a
similar general population of the United Kingdom, indicating a
potential lethal effect of the common genetic variant.
J-Point Elevation and ST-T Wave
Several studies have shown JPE to associate with an increased
risk of SCD in the general population (Haïssaguerre et al., 2008;
Tikkanen et al., 2009; Olson et al., 2011). We find three SNPs
to have a modest effect on the JPE in the general population,
indicating that there might be common variants associated with
JPE in the general population. Interestingly, the effect of risk
allele number on JPE was similar in both genders suggesting
that the male dominance of BrS is unlikely to be mediated by
either SCN5A, HEY2, nor SCN10A. Another SNP (rs6801957),
which is in perfect linkage disequilibrium (LD) (r2 = 1.00) with
rs6800541 intronic to SCN10A, has recently been associated with
ST-T wave amplitudes in a large GWAS on European individuals,
an ECG parameter closely related to the JPE (Verweij et al.,
2016).
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PR, QRS, and QTc Interval Prolongation
We found a statistically significant prolongation of the PR
interval when carrying the rs11708996 and rs6800541 risk
variants located intronic to SCN5A and SCN10A, respectively.
These findings are in line with the data presented by Pfeufer
et al. (2010), where the authors found the SCN5A and
SCN10A loci to prolong the PR interval and to decrease
the risk of AF (Pfeufer et al., 2010). These findings have
later been replicated in a Scandinavian cohort of lone AF
patients (Andreasen et al., 2014). In agreement with our data,
Sotoodehnia et al. (2010) have also showed the SCN5A and
TABLE 3 | Number of registered events in Danish health care registries,
(n = 6,161).
Event N
AF 144
BrS 0
Cardiac arrest 19
Syncope 144
Death from all causes 286
AF, atrial fibrillation; BrS, Brugada Syndrome.
SCN10A variants, or a variant in high linkage, to prolong
the QRS interval. A PR and QRS prolonging effect of BrS
risk variants supports that the cardiac depolarization process
has an important role in the BrS pathogenesis (Wilde et al.,
2010).
A previous GWAS has associated the rs11129795 loci in
SCN5A with a shortened QTc interval, in line with our results,
however, the QT interval GWAS loci is not in LD with our
TABLE 4 | Additive effect of BrS-associated risk alleles on J-point elevation in lead
V1.
Number
of alleles
N Mean J-point elevation
in lead V1, µV
95% CI P-value
0 428 3.5 (0.7–6.3)
1–2 3,575 7.4 (6.4–8.3) 0.0063†
3–4 1,912 8.3 (7.0–9.6) <0.001†
5–6 69 17.1 (11.0–23.2) <0.001†
CI, confidence interval; N, total number of individuals. Variants: SCN5A rs11708996; G/C,
risk allele C, SCN10A rs6800541; C/T, risk allele C, and HEY2 rs9388451, T/C, risk allele C.
†
Statistically significant compared to zero alleles with a P-value< 0.05 with Dunnett’s Post
Hoc Test. Age and sex adjusted.
FIGURE 1 | (A–C) Survival plot displaying the probability of survival during follow-up in different age groups in wildtype, heterozygote, and homozygote carriers of
three BrS risk alleles; HEY2 rs9388451, SCN5A rs11708996, and SCN10A rs6800541. (D) Survival plot displaying the probability of survival during follow-up in
different age groups when carrying 0, 1–2, 3–4, or 5–6 BrS risk alleles.
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SCN5A risk variant. The impact of the SNPs therefore serves to
validate prior work.
The RAFs in our Danish study population resembles the RAFs
of the control population in the original BrS GWAS (rs11708996;
0.15 vs. 0.15, rs6800541; 0.38 vs. 0.41, and rs9388451; 0.49 vs.
0.50), indicating that the populations are comparable.
The Role of BrS Risk Alleles in Overall
Mortality
We found none of the three BrS risk alleles to have an effect
on the risk of syncope, AF, or overall mortality in a general
population of Denmark. In order to investigate a similar general
population, we used 382,000 white British participants from UK
Biobank, and found the HEY2 risk allele rs9388451 to associate
with cardiac arrest/VF, indicating a potential lethal effect of the
common genetic variant. The HEY2 risk allele has been analyzed
in the GEVAMI study on Danes with ST-elevation myocardial
FIGURE 2 | The additive effect of carrying multiple BrS-associated risk alleles
on the JPE in lead V1. JPE (mean ± SE) as a function of number of risk alleles
(SNC5A rs11708996, SCN10A rs6800541, HEY2 rs9388451). JPE, J-point
elevation; SNP, single nucleotide polymorphism.
infarction (STEMI) and has been associated with a borderline
significant increased risk of VF [OR = 1.50 (95% CI: 0.96–2.40),
P = 0.070 in 257 patients with VF caused by STEMI compared
with 537 STEMI controls without VF; (Jabbari et al., 2017)],
further supporting our findings.
As the average age at the end of follow-up in our study was
almost 60 years, we could suspect potential BrS symptoms, due
to the three BrS risk alleles alone, to have developed, bearing in
mind that most BrS patients develop symptoms in their fourth
decade of life (Hedley et al., 2009). However these SNPs had
a significant effect on the JPE even in the general population,
which may explain why they act as modifiers in BrS patients
(Bezzina et al., 2013). This although common variants in general
are thought to have small effect sizes. A recent study has shown
rare variants previously associated with BrS to have no effect on
syncope, malignant cardiac arrhythmia, and all-cause mortality
in the general population (Ghouse et al., 2016). Diverging results
in previous studies calls for studies on larger patient populations
in order to understand the pathophysiological mechanisms of
BrS.
Limitations
In the Danish dataset only patients admitted to a hospital in
relation to syncope was included in the analyses. Also, it is not
possible with the current ICD-10 system to differentiate between
syncope caused by arrhythmia and vasovagal episodes. Registry
data on syncope was only available from the year 1994. The
youngest patients were included from the age of 29 years and
adverse life events might have occurred prior to the time of
inclusion, leaving a potential survival bias.
The association of the HEY2 loci with cardiac arrest/VF
is obviously very interesting but the association needs to be
replicated when an independent dataset of similar size becomes
available.
CONCLUSIONS
The three SNPs in HEY2, rs9388451, SCN5A, rs11708996,
and SCN10A, rs6800541 are associated with significant
FIGURE 3 | The additive effect of carrying multiple BrS-associated risk alleles on the JPE in lead V1 for males and females. JPE (mean ± SE) as a function of number
of risk alleles (SNC5A rs11708996, SCN10A rs6800541, HEY2 rs9388451). JPE, J-point elevation; SNP, single nucleotide polymorphism.
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FIGURE 4 | QQ plot of genome-wide single-variant association analyses in the
UK Biobank cohort. Markers are stratified by MAF between 0.5–0.02 and 5 ×
10−4 −1 × 10−4 shown with light blue and dark blue. Dots indicate observed
P-values (–log10[P-value]) compared with those expected by chance. The
gray line indicates the identity (no association) including the corresponding
95% CI under the null hypothesis (no association).
electrocardiographic changes in ST elevation, PR interval,
and QRS duration which may explain the effect in BrS patients.
An association of the HEY2 risk allele was found with cardiac
arrest/VF in the larger UK Biobank population indicating a
possible pathological role in cardiac arrhythmia.
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